Document Detail


Pharmacological vitrectomy.
MedLine Citation:
PMID:  10749315     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Pharmacological vitrectomy refers to the use of enzymes in an effort to liquefy vitreous and to weaken the adhesion of vitreous cortex to the internal limiting membrane during or before performing vitreous surgery. It is well known that the vitreoretinal interface plays important roles in developing many blinding diseases. To make the vitreous surgery easier for better outcome or to avoid vitrectomy, plasmin, dispase, and chondroinase have been used to promote the disinsersion of vitreous cortex to the internal limiting membrane, a basement membrane of Muller cells. On the other hand, hyaluronidase has been used clinically to facilitate the clearance of vitreous hemorrhage liquefying vitreous body and developing posterior vitreous detachment. This article reviews enzymes as an intraoperative adjunctive agent in vitrectomy.
Authors:
M Tanaka; H Qui
Related Documents :
2908755 - Balsalazide in the maintenance treatment of patients with ulcerative colitis, a double-...
382165 - Renal disease in pregnancy.
16487885 - Miscellaneous diseases affected by pregnancy.
6605595 - Studies on the pathophysiology and treatment of von willebrand's disease. vi. variant v...
8562065 - Carbendazim (mbc) disrupts oocyte spindle function and induces aneuploidy in hamsters e...
10494465 - Intrauterine resuscitation of the compromised fetus.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Seminars in ophthalmology     Volume:  15     ISSN:  0882-0538     ISO Abbreviation:  Semin Ophthalmol     Publication Date:  2000 Mar 
Date Detail:
Created Date:  2000-04-25     Completed Date:  2000-04-25     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  8610759     Medline TA:  Semin Ophthalmol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  51-61     Citation Subset:  IM    
Affiliation:
Department of Ophthalmology, Juntendo University Urayasu Hospital, Japan. eyeofjun@mb.infoweb.ne.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Collagenases / administration & dosage,  therapeutic use
Endopeptidases / administration & dosage,  therapeutic use
Enzymes / administration & dosage,  therapeutic use*
Eye Diseases / drug therapy,  surgery
Fibrinolysin / administration & dosage,  therapeutic use
Fibrinolytic Agents / administration & dosage,  therapeutic use
Humans
Hyaluronoglucosaminidase / administration & dosage,  therapeutic use
Injections
Retinal Diseases / drug therapy*,  surgery
Treatment Outcome
Vitrectomy / methods*
Vitreous Body / drug effects,  surgery
Chemical
Reg. No./Substance:
0/Enzymes; 0/Fibrinolytic Agents; EC 3.2.1.35/Hyaluronoglucosaminidase; EC 3.4.-/Endopeptidases; EC 3.4.21.7/Fibrinolysin; EC 3.4.24.-/Collagenases; EC 3.4.99.-/dispase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Tissue plasminogen activator in the treatment of vitreoretinal diseases.
Next Document:  Antibacterial therapy for Crohn's disease: a review emphasizing therapy directed against mycobacteri...